Clinical Trials Browser

GSK2879552 × Other hematologic neoplasm × Clear all

NCT02177812 2019-06-28

A Phase I Dose Escalation Study of GSK2879552 in Subjects With Acute Myeloid Leukemia (AML)

Phase 1 Terminated

41 enrolled 34 charts

Other hematologic neoplasm

Leukemia, Neoplasms, Leukemia, Myeloid, Acute